|Articles|September 7, 2013

Compliance by Design and Compliance Master Plans

Video with Paul Pluta

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

96-well microplate | Image credit: © Caleb Foster - © Caleb Foster - stock.adobe.com

New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models

ByFeliza Mirasol

December 2nd 2025

Ampoules vaccine from coronavirus with syringe 3d render illustration on white. | © mylisa - © mylisa - stock.adobe.com

Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths

ByFeliza Mirasol

December 1st 2025

Development and creation of coronavirus vaccine COVID-19 .Coronavirus Vaccine concept in hand of doctor blue vaccine jar. Vaccine Concept of fight against coronavirus. | Image credit: © Looker_Studio - © Looker_Studio - stock.adobe.com

CDC’s Policy Shift on Autism and Vaccines Spurs Biopharma Quality/System Concerns

ByFeliza Mirasol

November 21st 2025

speech bubbles concept 3d illustration | Image Credit: © frender - stock.adobe.com

Industry Experts Probe CNPV Impacts: Part I

ByChristopher Cole

November 21st 2025

A skilled technician examines a microfluidic device in a laboratory setting. | Image credit: © Vectplus - © Vectplus - stock.adobe.com

How Miniaturized Analytics Are Transforming Aseptic Bioprocessing Control

ByFeliza Mirasol

November 21st 2025

Compliance by Design and Compliance Master Plans

Newsletter

Related Content

New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models

Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths

CDC’s Policy Shift on Autism and Vaccines Spurs Biopharma Quality/System Concerns

Industry Experts Probe CNPV Impacts: Part I

How Miniaturized Analytics Are Transforming Aseptic Bioprocessing Control

Trending on BioPharm International

Implementing Automation and Flexible Design for Allogeneic Manufacturing

New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models

Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies

Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths

Emerging siRNA Platform Offers New Metabolic Disorder Therapies